Related Experiment Video
Updated: Jul 9, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Redirection of the reaction between activated protein C and a serpin to the substrate pathway
Andrey A Komissarov1, Peter A Andreasen, Paul J Declerck
1Department of Chemistry, Portland State University, P. O. Box 751, Portland, OR 97207-0751, USA. akomiss@pdx.edu
Insights
Targeting plasminogen activator inhibitor 1 (PAI-1) with specific antibodies can protect activated protein C (APC) from inactivation. This strategy enhances APC’s therapeutic potential in severe sepsis by neutralizing PAI-1.
Area of Science:
- Biochemistry
- Pharmacology
- Immunology
Background:
- Activated protein C (APC) is a crucial therapeutic agent for severe sepsis, but its efficacy is limited by inactivation from serine protease inhibitors (serpins).
- Elevated levels of plasminogen activator inhibitor 1 (PAI-1), a specific serpin, are linked to poor outcomes in sepsis and disseminated intravascular coagulation.
- Developing methods to protect APC from PAI-1 inactivation is essential for improving sepsis treatment.
Purpose of the Study:
- To investigate intermolecular mechanisms for redirecting the reaction between PAI-1 and APC.
- To explore the potential of neutralizing PAI-1 to enhance APC's therapeutic efficiency.
Main Methods:
- Utilized SDS PAGE and fluorescence spectroscopy to analyze the reaction kinetics and stoichiometry.
- Studied the effects of anti-PAI-1 monoclonal antibodies (mAbs), vitronectin, and their fragments.
Main Results:
- Monoclonal antibodies targeting the alpha-helix F region of PAI-1 redirected 70-80% of the APC-PAI-1 reaction to the substrate pathway.
- Vitronectin and its SMB domain enhanced the effect of mAbs but did not alter reaction stoichiometry.
- Vitronectin increased the APC-PAI-1 reaction rate, while mAbs and the SMB domain did not.
Conclusions:
- Ligands that bind to PAI-1's alpha-helix F can protect APC from inhibition, suggesting a therapeutic strategy.
- The universal nature of proteinase/serpin interactions allows for similar approaches to enhance the inactivation of other serpins, preserving APC activity.
- Targeting APC inhibitors pharmacologically offers potential therapeutic benefits in sepsis and related conditions.
Background:
Activated protein C (APC) reduces mortality in severe sepsis. Protecting APC in the circulatory system from inactivation by serine protease inhibitors (serpins) could improve its therapeutic efficiency. Significantly elevated levels of a serpin plasminogen activator inhibitor 1 (PAI-1) correlate with a lethal outcome in severe sepsis and disseminated intravascular coagulation. Intermolecular mechanisms were employed to redirect the reaction between APC and PAI-1 from the inhibitory to the substrate pathway, which results in the catalytic neutralization of the serpin.
Methods:
The effects of anti-PAI-1 monoclonal antibodies (mAbs) and vitronectin, as well as their fragments, on the kinetics and stoichiometry of the reaction between PAI-1 and APC were studied using SDS PAGE and fluorescence spectroscopy.
Results:
MAbs with epitopes at alpha-helix F redirected 70-80% of the reaction between PAI-1 and APC, to the substrate pathway. Vitronectin and its SMB domain did not affect the stoichiometry of acyl-enzyme formation, but enhanced the effect of mAbs. While vitronectin induced a more than two-fold increase in the rate of the reaction between PAI-1 and APC, neither mAbs (mAb fragments), nor SMB domain of vitronectin affected it.
Conclusions:
Ligands interacting with alpha-helix F of PAI-1 demonstrated a potential for the protection of APC from inactivation by PAI-1. Since the mechanism of proteinase/serpin interaction is universal, a similar design and approach could be employed for enhancing the inactivation of other serpins in order to preserve APC activity in the circulation. Rational pharmacological targeting of the inhibitors of APC could have therapeutic utility.
More Related Videos
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
cAMP-dependent Protein Kinase Pathways
The Unfolded Protein Response
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

